2024 Press releases
- New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery
Press release, 3 avril 2024 - Research agreement between Gustave Roussy and Amgen to predict the effectiveness of antibodies drug conjugates
Press release, 28 march 2024 - The Lancet - A clinical trial proves the efficacy of sunitinib in the treatment of rare neuroendocrine tumors
Press release, 12 march 2024 - Leading European oncology center Gustave Roussy adopts OncoDNA’s OncoDEEP® Kit and automates library preparation and Target Enrichment using Bravo instrument
Press release, 1 march 2024 - Dana-Farber and Gustave Roussy to hold third Transatlantic Exchange: Annual scientific conference dedicated to advancing Oncology research and practice
Press release, 27th february 2024 - Nature journal - An innovative vision of cancer classification is indispensible for research and for patients
Press release, 31th january 2024 - The Department of Therapeutic innovation and early stage trials strengthened by the appointment of professor Chirstophe Massard as its head
Press release, 17th january 2024
Catégorie de la page: